Eversept Partners LP Has $20.76 Million Holdings in Danaher Co. (NYSE:DHR)

Share on StockTwits

Eversept Partners LP trimmed its position in Danaher Co. (NYSE:DHR) by 8.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 145,104 shares of the conglomerate’s stock after selling 13,660 shares during the quarter. Danaher makes up approximately 5.9% of Eversept Partners LP’s holdings, making the stock its 5th largest position. Eversept Partners LP’s holdings in Danaher were worth $20,761,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. MBM Wealth Consultants LLC boosted its position in Danaher by 2.0% during the 2nd quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock worth $529,000 after acquiring an additional 74 shares during the period. Mechanics Bank Trust Department boosted its position in Danaher by 1.7% during the 2nd quarter. Mechanics Bank Trust Department now owns 4,384 shares of the conglomerate’s stock worth $627,000 after acquiring an additional 75 shares during the period. Adirondack Trust Co. boosted its position in Danaher by 3.1% during the 1st quarter. Adirondack Trust Co. now owns 2,635 shares of the conglomerate’s stock worth $349,000 after acquiring an additional 78 shares during the period. Cornerstone Advisors Inc. lifted its holdings in shares of Danaher by 2.9% in the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock valued at $367,000 after buying an additional 79 shares during the period. Finally, Copperwynd Financial LLC lifted its holdings in shares of Danaher by 1.9% in the second quarter. Copperwynd Financial LLC now owns 4,144 shares of the conglomerate’s stock valued at $592,000 after buying an additional 79 shares during the period. Institutional investors and hedge funds own 78.52% of the company’s stock.

Several analysts have recently weighed in on DHR shares. Robert W. Baird upped their price objective on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a report on Friday, July 19th. Piper Jaffray Companies upped their price objective on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Needham & Company LLC restated a “buy” rating and issued a $155.00 price objective (up previously from $142.00) on shares of Danaher in a report on Friday, July 19th. Argus upped their price objective on Danaher to $165.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Finally, Royal Bank of Canada set a $134.00 price objective on Danaher and gave the company a “hold” rating in a report on Friday, July 19th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Danaher has an average rating of “Buy” and an average price target of $143.54.

In other Danaher news, Chairman Mitchell P. Rales purchased 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were purchased at an average cost of $139.52 per share, with a total value of $348,800.00. Following the completion of the transaction, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Robert S. Lutz sold 14,668 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $143.28, for a total value of $2,101,631.04. Following the transaction, the chief accounting officer now directly owns 21,054 shares in the company, valued at $3,016,617.12. The disclosure for this sale can be found here. Insiders have sold 177,202 shares of company stock worth $25,175,829 over the last three months. 11.40% of the stock is owned by insiders.

Shares of Danaher stock traded up $0.59 on Friday, reaching $142.33. 13,457 shares of the company were exchanged, compared to its average volume of 1,917,615. The stock has a fifty day moving average price of $140.18 and a 200-day moving average price of $135.10. The firm has a market capitalization of $97.99 billion, a price-to-earnings ratio of 31.50, a price-to-earnings-growth ratio of 2.46 and a beta of 0.94. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $145.50.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to analyst estimates of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. Danaher’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.15 earnings per share. On average, equities analysts anticipate that Danaher Co. will post 4.79 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.48%. The ex-dividend date is Thursday, September 26th. Danaher’s payout ratio is 15.04%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: After-Hours Trading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Eversept Partners LP Has $15.71 Million Stake in Ascendis Pharma A/S
Eversept Partners LP Has $15.71 Million Stake in Ascendis Pharma A/S
Amarin Co. plc  Stock Holdings Lessened by Eversept Partners LP
Amarin Co. plc Stock Holdings Lessened by Eversept Partners LP
Eversept Partners LP Cuts Stock Holdings in Sanofi SA
Eversept Partners LP Cuts Stock Holdings in Sanofi SA
Eversept Partners LP Makes New $6.32 Million Investment in Alnylam Pharmaceuticals, Inc.
Eversept Partners LP Makes New $6.32 Million Investment in Alnylam Pharmaceuticals, Inc.
Eversept Partners LP Buys 8,930 Shares of argenx SE –
Eversept Partners LP Buys 8,930 Shares of argenx SE –
Eversept Partners LP Has $20.76 Million Holdings in Danaher Co.
Eversept Partners LP Has $20.76 Million Holdings in Danaher Co.


© 2006-2019 Ticker Report